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Abstract
People living in areas with active vector-borne transmission of Chagas disease have multi-
ple contacts with its causative agent, Trypanosoma cruzi. Reinfections by T. cruzi are possi-
ble at least in animal models leading to lower or even hardly detectable parasitaemia. In
humans, although reinfections are thought to have major public health implications by
increasing the risk of chronic manifestations of the disease, there is little quantitative knowl-
edge about their frequency and the timing of parasite re-inoculation in the course of the dis-
ease. Here, we implemented stochastic agent-based models i) to estimate the rate of re-
inoculation in humans and ii) to assess how frequent are reinfections during the acute and
chronic stages of the disease according to alternative hypotheses on the adaptive immune
response following a primary infection. By using a hybrid genetic algorithm, the models were
fitted to epidemiological data of Argentinean rural villages where mixed infections by differ-
ent genotypes of T. cruzi reach 56% in humans. To explain this percentage, the best model
predicted 0.032 (0.008–0.042) annual reinfections per individual with 98.4% of them occur-
ring in the chronic phase. In addition, the parasite escapes to the adaptive immune response
mounted after the primary infection in at least 20% of the events of re-inoculation. With
these low annual rates, the risks of reinfection during the typically long chronic stage of the
disease stand around 14% (4%-18%) and 60% (21%-70%) after 5 and 30 years, with most
individuals being re-infected 1–3 times overall. These low rates are better explained by the
weak efficiency of the stercorarian mode of transmission than a highly efficient adaptive
immune response. Those estimates are of particular interest for vaccine development and
for our understanding of the higher risk of chronic disease manifestations suffered by
infected people living in endemic areas.
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Author summary
Chagas disease is caused by a unicellular parasite mainly transmitted by blood-feeding
bugs. The disease starts with an acute phase when the parasite multiplies in tissues. The
immune system is then activated and almost clears the parasites before the host enters the
chronic phase of the disease. As hosts remain exposed to the vectors, secondary contacts
may result in re-inoculation with the parasite. The re-inoculated parasites then have to
face an adaptive immune response that may prevent reinfection. There is little quantitative
knowledge about the frequency of such re-inoculation and the efficiency of the immune
system to prevent them. Since reinfections can lead to people carrying two or more strains
of the parasite, we can potentially infer on the frequency of reinfection from the detection
of such mixed infections. We fitted agent-based models to field data to estimate the fre-
quency of reinfection in humans and its timing after primary infection. Our models pre-
dicted that most reinfections occur during the chronic phase as the adaptive immune
response fails to prevent them in 20% of re-inoculations. Such a rate of failure is particu-
larly important as reinfections are thought to increase the risk of heart damage in the
chronic phase of the disease.
Introduction
Chagas disease (American trypanosomiasis) is a vector-borne disease primarily transmitted by
a broad range of ecologically and evolutionary diversified triatomine species (e.g. [1]). Despite
multinational control initiatives [2], vectorial transmission is still active in several countries
and the disease remains a major public health concern in Latin America, where several million
people are at risk of infection.
The disease is characterized by a persistent infection with the parasite Trypanosoma cruzi.
High parasitaemia is typically observed in the acute stage of infection until the immune system
establishes an efficient, albeit not complete, control of the pathogen. Finally, the disease enters
a chronic stage where parasite persistence is associated with chronic manifestations of the dis-
ease [3–8]. In addition, this parasite persistence triggers a constant activation of the immune
system that is thought to exert a resistance to reinfections. This condition of non-sterile immu-
nity, known as premunition or premunity [9], has been described for several diseases like
malaria [10–12] and infections by helminthes [13–17]. Despite such a potential immune
response, there are evidences that reinfections actually occur in animal models of Chagas dis-
ease such as mice [18–22], dogs [23], guinea pigs [24] and hamsters [25]. Evidences about rein-
fections in humans are more restricted. Macedo and coworkers reported a possible case of
reinfection of a previously diagnosed man who developed an acute chagasic myocarditis in a
longitudinal study [26]. Additional evidences about reinfections in humans are indirect and
based on transversal studies assuming the vector exposure time as a synonymous of occurrence
of reinfections [27–29]. Several authors proposed a role of reinfections in pathogeny. Although
parasitaemia is lower in the reinfections compared to the primary infection in animal models
[20, 22, 23], reinfections may aggravate chronic disease in mice [20–22, 30, 31] and they may
be associated to chronic cardiac damage in humans [28, 29, 32]. To determine the frequency
of reinfections and the ability of the human immune system to prevent them is thus essential
to our understanding of the disease dynamics. In addition, it may help approaches for vaccine
development. Since reinfections in humans cannot be experimentally evaluated for obvious
ethical concerns, mathematical and computational models of Chagas disease transmission are
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critically needed to infer on the rate and timing of T. cruzi reinfections from epidemiological
field data.
Reinfections can cause mixed infections, i.e. infection with at least two different genotypes
of the same parasite. The analysis of mixed infections by T. cruzi may thus help gaining the
desired knowledge about human reinfections, provided that one is able to establish quantita-
tive predictions about the expected patterns of such mixed infections. We thus identified a
complete set of four hypotheses that can explain the occurrence of a mixed infection in a
human. Under a first hypothesis that we refer to as “Full Protection” (FP), no new parasite can
be permanently established in the host after a primary infection. A mixed infection can then
only result from the vector transmitting more than one lineage in the primary infective con-
tact. Second, under an “Acute-Phase Window” (APW) hypothesis, the adaptive immune
response is not completely established during the acute stage. Consequently, reinfections by
different lineages can then cause a mixed infection in this stage. Alternatively, reinfections can
be negligible in the short time of the acute phase, but they can occur in the chronic phase if the
adaptive immune response fails. We called this third hypothesis “Protection Failure” (PF). The
last hypothesis is a combination of the APW and the PF, so that reinfections may occur in
both phases of the disease. Such reinfections can cause mixed-infections.
In this paper, these four alternative hypotheses are modeled to predict the transmission of
T. cruzi major lineages (called ‘discrete typing units’—DTUs) [33, 34] that were detected circu-
lating in Chaco province, Argentina [35–37]. The predicted rates of mixed-infections are com-
pared to the observed pattern to infer on the rate of reinfection and to discriminate which of
the four different hypotheses about the host immune response has major relevance. This pro-
vides a simple conceptual background based on agent-based modeling in order to infer on the
rate of re-inoculations and the rate and timing at which re-inoculated parasites evade the
immune system to reach persistence in humans.
Methods
General overview of the methods
To test the four different hypotheses (FP, APW, PF and APW + PF), we developed an agent-
based model (ABM) of T. cruzi transmission. Briefly, an ABM is a computational model that
includes two main components: the environment and the agents. Our models simulated T.
cruzi transmission in an environment corresponding to a rural village made of contiguous
houses. Houses had different agents representing humans and bugs. These agents may have
different states (infected or non-infected). In addition, infected agents are infected by one or
more DTUs. Different rules were specified to describe the population dynamics of the agents,
according to typical birth, death and dispersal processes. In addition, other rules determined
the transmission of the parasites between hosts and vectors. Four different models were set
up by specifying transmission rules according to each of the hypotheses about the immune
response and the origin of reinfection (FP, APW, PF and APW + PF). For any set of demo-
graphic and transmission parameters, the models were run until the prevalence of infection in
humans (PH) and in vectors (PV), and the frequency of mixed infections in humans (Fmix) had
reached their equilibrium. Different approaches were then used to compare the predictions
obtained from the models and the epidemiological situation observed in the populations stud-
ied in the Gran Chaco. First, we fitted the models to the observed PV, PH and Fmix values. Pre-
dicted prevalences and likelihoods of the best fitted models were compared to evaluate the
ability of each of the hypotheses to reproduce the observed patterns. Second, we calculated the
probability for the different models to predict an Fmix as high as the observed value when val-
ues of different model parameters (i.e. mortality rates, transmission probabilities, etc.) freely
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vary within plausible biological ranges, which we refer to as uncertainty analysis. Third, a sen-
sitivity analysis was made to determine the specific influence of each parameter on the value of
Fmix. Finally, because intra-domestic reservoirs can potentially affect the prevalence and fre-
quency of mixed infections, we evaluated the robustness of our conclusions to the inclusion of
such a reservoir host. This model fitting and comparison approach allowed assessing the ability
of the four hypotheses to explain the infection patterns observed in the studied village of
Chaco and to concomitantly provide the first quantitative estimates of the rate of reinfection
in humans and the frequency of such reinfections in the acute and in the chronic stage of the
disease.
The Agent Based Model (ABM) of T. cruzi transmission
The components and the dynamical rules of our model are described below. Table 1 provides
a summary of all parameters including their definition and their typical range of values as
reported in the literature.
Table 1. Parameters of the Agent Based Models of transmission of Trypanosoma cruzi.
Parameter Description Range/value Reference/justification
Host and vector
population parameters
C Number of houses 100 Typical number of houses in rural villages from
Chaco
H Number of humans per house 5 [38]
V Number of vectors per house 50–500 [39]
B Feeding rate of vectors on mammals 0.09–0.31 feeding contacts
/bug/day in spring and
summer1.
[40]
MV Mortality of vectors 0.0045–0.0083 deaths /bug/
day
Corresponding to a life expectancy of 120–220
days according to mortality of 4-5th instars and
adults [41]
MH Mortality (plus emigration from village) of
humans
6.8 x 10−5–13 x 10−5 events
/human/day
Corresponding to an average lifetime in the village
of 21–45 years.
m Migration rate of vectors 0–0.02 events/vector/day Upper value set as twice the observed value [42]
N Nymph stage duration 60 days Duration of 4-5th instars [41].
T. cruzi transmission
parameters
TH->V Probability of transmission from human to
vector per contact
0.005–0.06 [43]
TV->H Probability of transmission from vector to
human per contact
2.6 x10-4–11 x10-4 [39]
Tmix,H->V Probability of transmission of a mixed
infection from human (with multiple DTUs)
to vector
0.4–0.9 Upper value set as under experimental conditions
[44] and unknown lower value set arbitrarily.
Tmix,V->H Probability of transmission of a mixed
infection from vector (with multiple DTUs)
to human
0.4–0.9 The range was set equal to Tmix,H->V
A Acute phase duration 0–90 days [45]
F Protection failure rate in the chronic phase:
probability of reinfection after re-
inoculation
0–1
1 the minimum feeding rate (on humans) was set as the mean of vector biting rates in spring and summer multiplied by the human blood index as
determined in [40].
https://doi.org/10.1371/journal.pcbi.1005532.t001
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Environment and agents. The environment is modeled by a squared grid of cells where
each cell represents a house. The dimension of the grid and the number of houses were set to
C = 10 x 10. Because transmission of T. cruzi to humans is maximal in spring and summer
[38], we accounted for seasonal transmission by allowing for new infections only during this
six months period. The human and vector agents are characterized by state variables. Humans
and vectors may be infected or not. Infected humans may be in the acute or the chronic phase
of the disease, and vectors can be nymphs or adults. Finally, all infected agents contain one or
more T. cruzi DTUs (TcI, TcIII, TcV and TcVI).
Population dynamics. The per house numbers of hosts (H) and vectors (V) were kept as
constant, which implied replacing any died agent by a new uninfected agent. This typical
assumption has been adopted for various models of T. cruzi transmission that include another
agent-based model of T. cruzi transmission [46] and compartmental models (see [47] for a
review). The modeling of population dynamics is then down to the description of mortality,
development and migration processes. The host and vector mortalities (MV and MH) were
both considered as constant, i.e. they were affected neither by seasonality nor by any individual
status (infection or stage of development), and vector development was modeled by assuming
that nymphs become adults after N days. Humans did not disperse within the grid as we
assumed that individuals sleep in the same house every night, where they can potentially be
infected. Only adult vectors could disperse with an m probability. We mimicked seasonal dis-
persal by setting m>0 in spring and summer, and m = 0 during the rest of the year. To keep
the model simple, the vector population size was constant in each house. Consequently, we
modeled dispersal as a switch of vector individuals between any two randomly selected houses
(from the entire grid) and we used an m/2 rate because the switch implies migration of two
individuals.
Transmission dynamics. The observed seasonality in transmission [38] was modeled by
considering a rate of contact per day between vectors and mammals (B) varying between the
two seasons, with B>0 in spring and summer and B = 0 in the rest of the year. The different
transmission rules that described our four hypotheses about the origin of mixed infection are
represented in Fig 1. In each potential infectious contact between an infected vector and a
non-infected human, a primary infection may begin with TV!H probability (Fig 1A). Infected
individuals can then be potentially re-infected either in the acute or in the chronic phase or
both phases of the disease (Fig 1B). During the acute phase window, whose duration is repre-
sented by A, the per-contact probability of reinfection is identical to the rate of primary infec-
tion TV!H, while in the chronic stage this probability is weighted by a factor F, where F is the
rate of protection failure. Within this framework, the ‘FP’ hypothesis was modeled by setting
A = 0 and F = 0, so that, in model ‘FP’, no reinfection was allowed either in the acute phase or
in the chronic phase. The ‘APW’ hypothesis was described in model ‘APW’, by allowing A to
take on positive values, while reinfections were still prevented in the chronic phase by setting
F = 0. The ‘PF’ hypothesis and model ‘PF’ was defined by setting A = 0 (no acute phase win-
dow), and allowing for reinfections in the chronic phase by letting F to be positive. The ‘APW
+ PF’ hypothesis was accounted for in model ‘APW + PF’ as A and F can take on positive val-
ues. Parasite transmission to vectors occurred with a probability TH!V (Fig 1C) that we
assumed to be constant. When transmission occurred from an individual (host or vector) car-
rying a mixed-infection, it involved either a single or several DTUs. We denoted Tmix,V!H and
Tmix,H!V, the probability of transmission of the mixed infection from an infected vector and
from an infected human, respectively (Fig 1D). When the transmission of a mixed infection
had occurred according to Tmix, all DTUs were transmitted (i.e. a human infected with TcI,
TcIII and TcV that transmit all their DTUs to the vector), otherwise only one randomly picked
DTU was transferred (i.e. just TcI, TcIII or TcV is transmitted with probability 1—Tmix).
Reinfection dynamics of Chagas disease
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Epidemiological field data
The different models were fitted to a previously published epidemiological dataset from two
neighbor rural settlements (El Palmar and Las Leonas) located in the Chaco Province of
Argentina, where vector-borne transmission is still active [37]. Prevalence data and frequen-
cies of mixed infections measured between 2008 and 2010 are presented in Table 2, and were
used as initial conditions to run the models. The prevalence in 276 vectors (Triatoma infestans)
captured from houses was determined by detection of the parasite in the bug faeces under
microscopic observation.
Model fitting by using a hybrid genetic algorithm. We implemented a hybrid genetic
algorithm in order to fit each model to the observed prevalences: PH, PV and Fmix. A genetic
algorithm (GA) is a global optimization method based on the idea of natural evolution in
order to select the combination of parameter values that maximizes a fitness function. The
potential solution of a problem is encoded on an ordered data structure called chromosome,
and the algorithm works on a population of several chromosomes [49]. Here, the population
size was set to 50 chromosomes and the combinations of parameters values bear by each of
Fig 1. Rules of T. cruzi transmission according to the four hypotheses on reinfections. (A) Transmission from vector to uninfected humans with
probability TV!H. (B) Definition of the four rules of reinfections. Full Protection (FP); Acute Phase Window (APW); Protection Failure (PF); Acute Phase
Window and Protection Failure (APW + PF); A, acute phase window duration; F, protection failure rate. (C) Transmission from human to vectors with
probability TH!V. (D) Transmission of mixed infections. Tmix is the probability of transmission of a mixed infection and z a random number uniformly
distributed between 0 and 1. The transmission of the mixed infection occurs when z < Tmix, and a single randomly selected DTU is transmitted otherwise.
https://doi.org/10.1371/journal.pcbi.1005532.g001
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those chromosomes were randomly generated by using a Latin hypercube sampling. Each
chromosome was evaluated for their fitness using simulated likelihood calculated as follow.
Average predictions for PH, PV and Fmix were obtained from 1,000 simulations of the ABM ran
with the parameter values bear by the chromosome. The probability mass function of the bino-
mial distribution was then used to estimate the likelihood of such predicted values conditioned
on the observed values in the host and vector populations. For example, the likelihood of the
predicted PH is calculated by using probability mass function with the observed number of
infected people (number of successes), the population size (number of trials) and PH (probabil-
ity of success) as parameters of the function. The product of such likelihoods was used as a
measure of fitness. Different operators (i.e. selection, recombination and mutation) are applied
to the population of chromosomes every generation in order to ‘evolve’ towards an optimal
solution. First, the twenty-five chromosomes with best likelihood were selected to populate the
next generation in the algorithm and the remaining were discarded. A ‘clonality plus mutation’
operator was then applied to the six best chromosomes to simulate a simple hill-climbing algo-
rithm and speed up the search for the global optimum [50]. Briefly, each selected chromosome
was copied and mutated in a single parameter at random to generate a descendant chromo-
some. The mutation consisted on the replacement of the selected parameter value by another
random value. However, in order to get a cloned chromosome which solution is a neighbor of
the solution of the parental chromosome (a step of a hill-climbing algorithm), the mutation
was limited such that the change is as maximum 10% of the parameter value. The second oper-
ator was recombination. The twenty-five best chromosomes were selected to recombine using
a roulette wheel approach with a single-point recombination [51] until the next generation of
the chromosome population is complete [52]. Third, the mutation operator was applied to all
chromosomes but the ten fittest ones (elitism) and the six clonal descendants that had already
been mutated. The mutation rate was then high (30%) to prevent premature convergence and
Table 2. Prevalence of infection in humans, dogs and vectors.
Prevalence of infection % (95% CI)†
Prevalence in human (PH) 1 44.1 (39.9–48.3)
Prevalence in vector (PV) 2 17.0 (13.1–21.9)
Prevalence in dogs (PV) 3 20.4 (16.4–25.2)
Prevalence of single infection in humans (Fsingle) 43.4 (33.2–54.1)
TcI 1.2 (0.2–6.5)
TcIII 0.0 (0.0–4.4)
TcV 36.1 (26.6–46.9)
TcVI 6 (2.6–13.3)
Prevalence of mixed infection in humans (Fmix) 4 56.6 (45.9–66.8)
TcI/TcV 3.6 (1.2–10.1)
TcI/TcVI 1.2 (0.2–6.5)
TcIII/TcV 1.2 (0.2–6.5)
TcV/TcVI 38.6 (28.8–49.3)
TcI/TcV/TcVI 12.0 (6.7–20.8)
1 Calculated as the percentage of people with at least two positive serological tests.
2 Determined by microscopic observation of faeces collected from intra-domiciliary bugs.
3 Estimated by using ELISA-test.
4 Percentage of mixed infections among individuals with positive kDNA-PCR (infected individuals according
to diagnostic PCR).
†Confidence intervals calculated from the Wilson binomial approximation for a proportion [48].
https://doi.org/10.1371/journal.pcbi.1005532.t002
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any mutation was generated by selecting a random value in the entire range of the model
parameter. The algorithm was run until convergence was reached. Finally, a simple hill-climb-
ing algorithm is applied to the best chromosome [50] to look for any minor improvement in
the likelihood.
The high number of replications and sample sizes of human and vectors implied stability of
the average estimates PH, PV and Fmix after 1,000 replications (standard errors by bootstrap <
0.5%), which suggest consistency of the estimators [53]. Consequently, we applied standard
likelihood methodologies to statistical analysis. The simulated likelihoods of the optimized
models were compared using the Likelihood Ratio Test. In addition, a confidence interval for
the F parameter was estimated using the profile likelihood method with profile likelihood
approximated from GA searches where F was increased from 0.1 to 1 by 0.1 steps.
Uncertainty and sensitivity analyses
An uncertainty analysis was performed in order to test how variation of different parameter
values in their biological ranges affects the predictions of Fmix. Particularly, the Fmix was ob-
tained for each one of 1,000 uniformly distributed samples of the parameter space. We used a
Latin hypercube sampling scheme as in [54]. The probability of predicting an Fmix as high as
the observed (FmixPredicted  FmixObserved) was calculated.
A sensitivity analysis was performed to determine the impact of variation in the parameter
values on the predictions of the best model. For each parameter, we used two standard mea-
sures of sensitivity; a coefficient of determination (R2) and a Pearson correlation coefficient (r)
that were calculated between the parameter values and the estimated frequency of mixed-infec-
tion Fmix. In addition, a variance-based sensitivity analysis to determine the total effect index
(STi) which provides a measure of the contribution of each parameter to the variance of Fmix.
STi was estimated by using the Jansen estimator and a Latin hypercube sampling of the param-
eter space with one-hundred matrices generated by radial sampling according to [55]. The val-
ues of R2, r, and STi obtained for each parameter were normalized by dividing by the sum of
values for all the parameters in order to be compared in a single graph.
Robustness analyses
Since heterogeneity in exposure between hosts can potentially influence the rate of infection
and reinfection in humans, we tested if the outcomes of our model selection approach were
robust to the existence of between households heterogeneity in vector distribution. We intro-
duced such heterogeneity in our full protection model to establish if those variations in vector
abundance could lead to a better fit. Heterogeneity in vector abundance was modeled by using
a negative binomial distribution with a mean number of vectors per house (Vmean) and an
aggregation parameter (kV). The range of kV values was set to 0.01–1000. A value of kV = 0.01
with Vmean = 100 implies that 50% of the houses are not infested, while the other 50% house-
holds receive all the 10000 vectors, with 12% of houses being infested by>500 vectors. On the
other hand, a value of kV = 1,000 with a Vmean = 100 implies little aggregation as about 99.5%
of the houses will have at least 80 vectors.
Since dogs represent a well-known risk factor for T. cruzi transmission to humans [38], we
analyzed if the inclusion of such a domestic reservoir could substantially change our estimates
of the frequency of mixed infections. The ‘FP’ and the ‘APW + PF’ models were thus re-fitted
to the data (using the hybrid GA method) while up to two reservoir individuals were added to
each house. Vector preference for human was then varied between 0.3 and 0.7 according to
observed levels of human blood index [40], and the rate of mortality of reservoirs was varied
between 0.0009 and 0.0027 to account for an average lifespan of 1–3 years. The per-contact
Reinfection dynamics of Chagas disease
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005532 May 8, 2017 8 / 21
probability of transmission from vectors to reservoirs (TV!R) was varied between 2.6 x 10−4
and 2 x 10−2, and the per-contact rate of transmission from reservoirs to vectors (TR!V) was
set to 0.49 according to available estimates [43]. In addition, we addressed the possibility of a
heterogeneous distribution of reservoirs per house. In this regard, we implemented a negative
binomial distribution with the mean number of reservoirs per house (Rmean) and the aggrega-
tion parameter kR. The range of values for kR was set to 1–10,000. kR = 1 and Rmean = 1 implies
that a mean of 50% of the houses will have no reservoirs.
Estimation of the frequency of effective re-inoculations and reinfections
We distinguished effective re-inoculation, i.e. the entrance of the parasite in an infected
human by avoiding the first barriers of defense (skin and innate immune response) from rein-
fection that follow re-inoculation. Such reinfection only occurs if the established adaptive
immune response fails to clear the re-inoculated parasite. To infer on each of these stages we
calculated both the frequency of re-inoculations and the frequency of reinfections.
The number of re-inoculations during a t-days period of time (Ir) was assumed to follow a
binomial distribution
Ir  Bðt  n; TV!HÞ ð1Þ
where n, the number of potential infective contacts per day and per human, is given by
n ¼ V  B  PV=H ð2Þ
Accordingly, the mean number of effective re-inoculations (Īr) was calculated as
I r ¼ t  n  TV!H ð3Þ
We used Eq 3 to estimate the mean number of effective re-inoculations during the acute
phase window (i.e. t = 60 days), and to predict the total number of effective re-inoculations by
replacing t by the exposure time per year (180 days) multiplied by the number of years lived
after infection.
Similarly, the average number of reinfections during the chronic phase (Īreinf) was estimated
from the expectation of a Binomial distribution where t stood for the duration of the chronic
stage and TV!H was lowered by the rate of protection failure rate (F), so that:
I reinf ¼ t  n  F  TV!H ð4Þ
Results
Full protection hypothesis is an unlikely explanation for the observed
frequency of mixed infections
We first assessed the ‘Full Protection’ hypothesis using our ABM set with the FP transmission
rule that does not allow for any reinfection (Fig 1B). The best fit of the FP model to the PH, PV
and Fmix observed in the rural villages (Table 2) is shown in Table 3 (see also S1 Fig and S1 Table
for details about parameter estimates). The model predicted an Fmix substantially lower than the
value observed in our study area (Table 3). Even when parameters values were allowed to vary
within their biologically plausible ranges, the probability of predicting an Fmix Fmixobserved
remained very low (p = 0.002). Taken together, these analyses strongly suggest that the level of
mixed infections measured in the villages of Chaco is unlikely to be reached if full protection is
assumed and no reinfection is possible.
Reinfection dynamics of Chagas disease
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Reinfections are rare in the acute phase of the disease
We evaluated if the hypothesis of reinfections during the acute phase window may provide a
better explanation to the observed level of mixed infections. The ABM set with the APW rule
of transmission (Fig 1B) provided a slightly better fit than the model with no reinfection, as
indicated by a marginally higher likelihood (Table 3). However, this second model did not
allow for a major increase in the predicted value of Fmix that remained similar to the value pre-
dicted in the absence of reinfection. The uncertainty analysis confirmed that trend as the prob-
ability of predicting an Fmix Fmixobserved remained very low (p = 0.004) when parameters
values were varied within their biological range. Such a conclusion is better understood when
quantifying the actual risk of reinfection during the acute phase, which can be made using Eq
1 and the estimated values of the model parameters (S1 Table). This risk of reinfection is very
low as it only equals 0.0061, which implies one reinfection every 164.2 primary infections.
Protection failure of the immune response explains the high frequency of
mixed infections
We evaluated if the protection failure in the chronic stage (model PF, Fig 1B) can explain the
high levels of mixed infection observed in our study area. The likelihood of the model PF was
indeed significantly higher than the likelihood of the basic FP model (Table 3). In addition, the
fitted model predicted an Fmix = 55% that nearly matched to 56% observed in the study area
(Table 3 and S1 Fig). The best fit was obtained for a rate of protection failure (F) equal to 0.77,
although Fig 2 indicates that a similar description of the data could be obtained for a large
range of F values (F 0.2) as the Log-likelihood is not reduced by more than 2 (the threshold
used to derivate confidence intervals of MLE estimates). As a matter of fact, when the value of
F is increased, the estimates of the probabilities of transmission of a mixed infection (Tmix,H->V
and Tmix,V->H) take on larger values to match the observed frequency of mixed infection,
although these variations remain bounded within 0.65 (when F = 1) and 0.90 (when F = 0.2).
Accordingly, a safe outcome of the fitting of the PF model is that, the rate of protection failure
must be larger than 20% to reproduce the frequency of mixed infection, i.e. at least 1 out of 5
re-inoculations typically lead to reinfection.
The addition of the acute phase window (model APW+ PF) did not provide a significantly
better fit than the PF model (Table 3). This is consistent with the outcome of the analysis of the
Table 3. Predicted prevalences, probabilities and Log-Likelihoods for different fitted models.
Models
Observed FP APW PF APW+PF FP + kV FP +reservoir APW+PF
+reservoir
FP + reservoir +
kR
PH 0.441 0.42 0.43 0.43 0.43 0.46 0.45 0.44 0.42
PV 0.17 0.21 0.18 0.18 0.17 0.21 0.19 0.17 0.23
Fmix 0.566 0.34 0.35 0.55 0.57 0.34 0.33 0.54 0.38
Ln(L) -19.5 -17.1 -8.7 -8.6 -19.3 -18.8 -8.7 -18.5
p(LR) 1 - 0.03 3.3 x10-6 1.9 x10-5 na na na na
p(FmixFmixobserved)2 0.003 0.001 0.475 0.501 <0.001 <0.001 0.276 <0.001
PH, mean prevalence of infected humans. PV, mean prevalence of infected vectors. Fmix, mean frequency of humans with mixed infections. kV, aggregation
parameter for heterogeneous distribution of vectors per house. KR, aggregation parameter for heterogeneous distribution of reservoir hosts per house.
1Likelihood ratio test against model FP.
2Probability for the fitted model to predict an Fmix equal or higher than the observed value.
https://doi.org/10.1371/journal.pcbi.1005532.t003
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APW model where reinfections in the acute phase window were shown to be of negligible
importance. It is also consistent with the best fit of model APW + PF that predicted an average
of 98.4% (SE = 0.2%) of the reinfections occurring in the chronic phase. The Fmix predicted by
the model was sensitive to variations in some parameter values. As expected, the prediction of
the model was most sensitive to variations in the F parameter that has a direct effect in increas-
ing Fmix (Fig 3). Other parameters with high effect on the Fmix included the number of vectors
per house, the biting rate and transmission parameters (TV->H and TH->V) whose variations
were positively related to Fmix. Despite such sensitivities, the uncertainty analysis showed that
the model predicted high levels of reinfections in a large part of the parameter space (p = 0.73
for Fmix Fmixobserved in the uncertainty analysis). This confirmed the model with protection
failure does provide much better predictions than any of the considered alternatives.
Repeated re-inoculations and reinfections are rare events
We took advantage of the predictions of the model PF to derive the expected frequency of
effective re-inoculations and reinfections. Interestingly, 4%, 18% and 70% of individuals were
found to be re-inoculated with the parasite at least once after 1, 5 and 30 years following the
primary infection (Fig 4A). Since the corresponding risk of reinfection clearly depends on the
rate of failure of the immune response, we derived the distributions of the number of reinfec-
tions for both the best estimate of F (F = 0.77) as well as for the lower (F = 0.2) and upper
(F = 1) limit of the range of F values that provided a good fit to the data (Fig 3). The risks of
individual reinfection after 1, 5 and 30 years of chronic infection were shown to be 3%, 14%,
60% when calculated with the best estimate of F (Fig 4C). They decreased to 0.8%, 4% and 21%
when estimated from lowest allowed rate of failure (Fig 4B). On the contrary, when the
Fig 2. Approximated profile likelihood for the rate of protection failure (F) in the model PF. Dashed
lines represent the lower and upper limit of the range of F values providing a good fit to the data.
https://doi.org/10.1371/journal.pcbi.1005532.g002
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immune response was considered to be totally inefficient (F = 1), so that re-inoculations are
strictly equivalent to reinfections, these risks increased to their maximum and reach 5%, 18%
and 70% (Fig 4A). In all cases, the number of per individual reinfections hardly ever exceeded
4 (Fig 4A–4C). Accordingly, despite a rate of protection failure estimated to be at least 20%,
reinfections remain rare events in the rural villages of our study area.
Robustness analysis
Our models assume non-heterogeneity in exposure to infection and re-infection e.g. each
house has the same number of vectors. In order to evaluate if heterogeneity in exposure may
bias our conclusions, we have modified the FP model by including heterogeneity in the num-
ber of vectors per house (FP + kV). Such heterogeneity was modeled by using a negative bino-
mial distribution. The best FP + kV model did not fit the data better than the FP model
(Table 3). Consequently, heterogeneity in the number of vectors per house cannot explain the
high frequency of mixed infections.
To evaluate if the inclusion of animal reservoirs may bias our conclusions by causing high
frequency of mixed infections in vectors and subsequently in humans, we added up to two res-
ervoir individuals per household to the basic model (FP) and to our best model (PF) that were
then fitted again. These more complex models did well predicting a low prevalence of infection
in reservoirs, which was concordant with observed values in the study area, but they did not
provide a significantly better fit to the frequency of mixed-infection in humans than the previ-
ous version of models FP and PF (Table 3). In addition, including heterogeneity in the number
of reservoirs per house using a negative binomial distribution does not improve the fit of the
FP model (Table 3).”
Fig 3. Sensitivity analysis of the frequency of mixed-infections (Fmix) predicted by the best model
(APW + PF). The sensitivity of the prediction to each parameter is quantified by three standard and
normalized measures: R2 (black bars), Pearson correlation coefficient (dashed bars) and total effect index
(STi) (dotted bars). The negative values of the coefficient of correlation indicate a decrease in the expected
frequency of mixed-infection when the parameter value is increased.
https://doi.org/10.1371/journal.pcbi.1005532.g003
Reinfection dynamics of Chagas disease
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005532 May 8, 2017 12 / 21
Fig 4. Frequency of re-inoculations and reinfections based on the best model (PF). (A) Distribution of
the number of effective re-inoculations per individual one-year (black bars), five-years (dashed bars) and
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Discussion
Despite the large-scale international control initiatives launched during the nineties to elimi-
nate triatomine populations, human infection with T. cruzi remains predominantly associated
with vector transmission [56]. In areas where human communities are highly exposed to vec-
tors, the annual number of potentially infectious bites per human can potentially reach 13–340
[39]. With such levels of risk, such as in the Chaco region, not only the prevalence of Chagas
disease can remain as high as 55–97% (e.g. [57], [58]), but we also expect individuals will face
multiple reinfections as the immune response mounted during primary infection is likely not
to be fully protective [59]. While such reinfections are thought to have important effects on
cardiomyopathy [28, 29, 32] and the probability of congenital transmission [60], little is
known about their frequency in rural communities. To determine the amount of reinfections
per individual thus remains a key challenge to improve our understanding of the disease
dynamics and its impact on the populations. For obvious ethical reasons, reinfections in
humans cannot be experimentally evaluated, and estimates of the rate and timing of T. cruzi
reinfections thus rely on indirect approaches based on a combination of epidemiological data
and models of T. cruzi transmission. Although various models have been developed to explain
the prevalence of Chagas disease in humans [38–40, 46, 47, 61–65], most of them typically con-
sider a single parasite and provide no prediction about the frequency of reinfection (see [47]
for a review). In this paper, we developed an agent-based modelling approach that account for
infection by multiple T. cruzi DTU, and therefore allows evaluating the frequency and timing
of reinfections in humans.
Using epidemiological field data from two rural villages from Chaco (Argentina) we identi-
fied two models of transmission (PF and APW + PF) that reproduce the epidemiological pat-
terns observed in the field, for parameter values within the range of previous estimations
[39,40,43,66–69]. This accuracy and the sensitivity analyses we performed suggest that while
the models remained parsimonious, they included the most relevant factors underlying the
dynamic of transmission in the studied area. The results derived from these models allowed us
to infer about the rate and timing of T. cruzi reinfections from epidemiological field data.
The first important outcome of our study is to show that only mixed primary infections
cannot explain the observed frequency of mixed infections in humans. Not only reinfections
in the chronic phase are necessary to explain the epidemiological data in the two studied locali-
ties of the Chaco area, but also, for such reinfections to be frequent enough, the rate of failure
of the protective immunity mounted after the primary infection by T. cruzi has to be at least
20%. Such estimate clearly shows that in humans, just as it has been shown experimentally in
mice [59] and dogs [23], reinfections are far from being fully prevented by adaptive immunity.
We shall point out that our estimate of a rate of failure of the adaptive immune response
greater than 20% was obtained under the simplifying assumptions that all DTUs confer the
same protection against reinfections and that different lineages have the same probabilities of
transmission. Considering heterogeneity in host immunity and/or filtering of the different
DTUs [70–73] would typically reduce the predicted frequency of mixed infections, and a
higher protection failure rate will then be required to fit the frequency of mixed infections
observed in the study area. On the other hand, the high rate of mixed infections in people
from El Palmar and Las Leonas was detected using highly sensitive hybridization assays with
specific probes from minicircle hypervariable regions (mHVRs) [37]. This marker, which
thirty-years (white bars) after the primary infection. (B and C) Distribution of probability of reinfection one-year
(black bars), five-years (dashed bars) and thirty-years (white bars) after the primary infection considering (B)
F = 0.2 and (C) F = 0.77.
https://doi.org/10.1371/journal.pcbi.1005532.g004
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allows DTU assignment directly from biological samples, has revealed high frequency of
mixed infections in other epidemiological contexts [74–78]. A possible drawback of such a
marker could be a reduced specificity. However, even if the method was not fully specific and
over-estimated mixed infections, accounting for a typical 80% of specificity would lead to a
true frequency of mixed infections reaching 46% (instead of 56.6%, see Table 2). Such a fre-
quency would thus remain high and, again, only models taking into account a protection fail-
ure during the chronic stage (i.e. PF and APW + PF) would be able to predict such level of
mixed infections (see Table 3). Our predictions about the failure of the adaptive immune
response and the rate at which it allows reinfection thus seems robust outcomes of this study,
and those quantitative findings are consistent with experimental measurements of the rate of
(non-) immunization after priming of the immune response that were shown to reach 40–50%
in mice [79], 47%-61% in Guinea pigs [80] and 46% in dogs [81].
The second main outcome of the model is to provide indirect estimates of the frequency
distribution of reinfection in humans. It has been repeatedly proposed that infected people liv-
ing in endemic areas suffer from frequent reinfections, and that such reinfections increase the
strength of cardiomyopathy in humans [28, 29, 32], just as they do in mice [20–22, 30, 31].
Although those epidemiological studies were based on sound statistical comparisons between
individuals with different levels of exposure to vectors, none of them provided estimates of the
actual level of vector-human contacts and its associated number of reinfection events per per-
son. Fitting our model of T. cruzi transmission to eco-epidemiological data collected in two vil-
lages of Chaco, we provided the first estimate of the frequency of human reinfection. We
indeed showed that 3% (0.8%-5%), 14% (4%-18%) and 60% (21%-70%) of individuals are re-
infected after 1, 5 and 30 years of the chronic stage of the disease. Those quantitative figures
are partially explained by the very low probability of stercorarian transmission of T. cruzi. Our
estimation of such probability of transmission (4.9 x 10−4 for the PF model) is highly consistent
with the rare estimates present in the literature [39, 40]. It seems indeed not fully appreciated
that given the extremely inefficient mode of T. cruzi transmission, one cannot expect reinfec-
tions to happen even on an annual basis. Considering the 20–30% of infected people that
develop a potentially life-threatening heart disease [56], and assuming that they correspond to
the individuals suffering with the most reinfections, they would typically be re-infected 1–2
times every 10 years according to the estimates of this study. Such a frequency appears unlikely
to be enough to sustain antigen exposure, the consequent inflammatory response at a high
chronic level, and a resulting higher cardiac morbidity. Surely, we must point out that our esti-
mates were derived in a specific entomological context that can be better characterized by cal-
culating the annual number of potentially infectious contacts per human, which we found to
be equal to 86 in our study area. This value lies slightly below average for T. infestans and it
represents a fourth of the maximal value reported in the literature [39]. We thus simulated a
four-fold increase in this standard measure of exposure to vectors. Noteworthy, such an excep-
tional level of exposure made the 20–30% most re-infected individuals to be re-infected 2–5
times every 10 years, which still not correspond to yearly reinfections.
A last outcome of our study came as a by-product of our analysis of the robustness of our
modeling outcome to the presence of reservoirs. Dogs have been demonstrated to be a major
risk factor of house infestation not only for key vector species adapted to human households,
such as T. infestans [38, 82, 83], but also for non-domiciliated species such as T. dimidiata [84].
They have further been shown to be intra-domiciliary reservoirs whose presence increases the
prevalence of infection in T. infestans [38, 85]. By contrast, our modeling showed that, in the
eco-epidemiological context encountered in El Palmar and Las Leonas, the presence of 1–2
reservoirs only slightly increases the prevalence of T. cruzi infection in vector and human, and
they were not necessary to explain the observed levels of mixed infections. These constitute
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indirect evidence that dogs may not be significant intra-domiciliary reservoirs in these villages,
which is consistent with their prevalence of infection with T. cruzi being twice as low as in
humans (Table 1), and with the inhabitants reporting that dogs do not sleep indoors. The situ-
ation in the two studied villages thus contrasts with reported studies on several other rural vil-
lages from northwestern Argentina, where >40% of dogs were infected and considered to be
relevant for the household transmission cycle [38, 85]. This suggests that the variation in the
actual impact of potential reservoirs can be large enough for keeping dogs outside of dormito-
ries to be efficient in lowering transmission to human, a control strategies that was earlier sug-
gested by a different modeling approach [38].
As a concluding remark, we would like to emphasize that, although the immune system can
prevent high parasitaemia after T. cruzi re-inoculation (as most experimental vaccines against
T. cruzi do), this does not appear to be efficient enough to prevent reinfections. The latter
would, nonetheless, remain rare events as T. cruzi stercorarian transmission put a providen-
tially strong limit on human primary and secondary infections.
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